Image
Buffing Up on New and Emerging ART A Look at the Changing HIV Playing Field

José Arribas, MD & Onyema Ogbuagu, MBBCh, FACP, FIDSA

This activity is jointly provided by Global Education Group and Integritas Communications. 

 

This educational activity is supported by an educational grant from Gilead Sciences, Inc.

Faculty

José Arribas, MD
Infectious Diseases Unit
Internal Medicine Service
La Paz University Hospital
Madrid, Spain

Onyema Ogbuagu, MBBCh, FACP, FIDSA
Associate Professor of Medicine
Director, HIV Clinical Trials Program
Section of Infectious Diseases
Yale School of Medicine
New Haven, Connecticut

Program Description

Antiretroviral therapy (ART) options with novel routes of administration have recently become available and several additional options are in clinical trials. These advances are accompanied by the need for changes to clinic infrastructure and novel implementation strategies. Buffing Up on New and Emerging ART: A Look at the Changing HIV Playing Field is a multimedia training program consisting of three 10-minute circuits that will boost your endurance and strengthen your expertise in using new and emerging ART options with novel routes of administration in HIV management. Drs. Onyema Ogbuagu and Jose Arribas walk learners through novel ART options, patient perspectives, clinical trial data, clinic models, workflow challenges, and the future of long-acting ART.

Target Audience

The educational design of this activity addresses the needs of US- and EU/UK-based infectious disease and HIV specialist physicians, nurse practitioners (NP), and physician assistants (PA), and provides information to keep them up-to-date on the rapidly evolving treatment armamentarium.

Learning Objectives

After completing this activity, participants will be better prepared to:

  • Describe recent advances in HIV management, including novel routes of administration and dosing frequencies

  • Review mechanism of action, safety, and efficacy data of new and emerging ART options

  • Identify strategies to incorporate new and emerging ART regimens into clinical practice

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 0.5 contact hour(s) (which includes 0.2 hour(s) of pharmacology).

Disclosure of Conflicts of Interest

Global Education Group adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the ACCME and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

José Arribas, MD - Consulting Fee: Janssen, Gilead Sciences, Inc, MSD, Teva, Alexa, Serono, Lilly, ViiV Healthcare; Contracted Research: Gilead Sciences, Inc., ViiV Healthcare; Speakers’ Bureau: Gilead Sciences, Inc., ViiV Healthcare, Janssen, MSD

Onyema Ogbuagu, MBBCh,FACP, FIDSA - Consulting Fees: Gilead Sciences, Inc., ViiV Healthcare

The planners and managers have the following relevant financial relationships with ineligible companies:

Kristin Delisi, NP: Nothing to disclose
Lindsay Borvansky: Nothing to disclose
Andrea Funk: Nothing to disclose
Liddy Knight: Nothing to disclose
Ashley Cann: Nothing to disclose
Gena Dolson, MS: Nothing to disclose
Rose O'Connor, PhD, CHCP: Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group and Integritas Communications do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions to Receive Credit

In order to received credit, participants must complete the following:

  1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
  2. Complete the Preactivity Questions.
  3. Review the activity content.
  4. Achieve a grade of 70% on the Postactivity Test Questions and complete the Evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Global Education Group Contact Information

For information about the accreditation of this program, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

credit amount 0.50

credit type CME/AANP

release 07/26/2022

expiration 07/26/2023

type Webcast